Population Characteristics, Symptoms, and Risk Factors of Idiopathic Chilblains: A Systematic Review, Meta-Analysis, and Meta-Regression
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Search Strategy and Selection Criteria
2.2. Data Extraction
2.3. Risk of Bias Assessment and Certainty of Evidence
2.4. Meta-Analysis
2.5. Meta-Regression
3. Results
3.1. Chatacteristics of Included Studies
3.2. Risk of Bias Assessment Results
3.3. Meta-Analysis and Meta-Regression
3.4. Certainity of Evidence Outcomes
4. Discussion
Strenghts and Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Lewis, T. Observations on Some Normal and Injurious Effects of Cold upon the Skin and Underlying Tissues: III. Frost-bite. Br. Med. J. 1941, 2, 869–871. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- McCleskey, P.E.; Zimmerman, B.; Lieberman, A.; Liu, L.; Chen, C.; Gorouhi, F.; Jacobson, C.C.; Lee, D.S.; Sriram, A.; Thornton, A.; et al. Epidemiologic analysis of chilblains cohorts before and during the COVID-19 pandemic. JAMA Dermatol. 2021, 157, 947–953. [Google Scholar] [CrossRef] [PubMed]
- Souwer, I.H.; Bor, J.H.; Smits, P.; Lagro-Janssen, A.L. Nifedipine vs placebo for treatment of chronic chilblains: A randomized controlled trial. Ann. Fam. Med. 2016, 14, 453–459. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gorouhi, F. Chilblains-like Nonischemic Eruption During the COVID-19 Pandemic-Distinct Features in Adolescents. JAMA Netw. Open 2021, 4, e2111676. [Google Scholar] [CrossRef] [PubMed]
- Ozmen, M.; Kurtoglu, V.; Can, G.; Tarhan, E.F.; Soysal, D.; Aslan, S.L. The capillaroscopic findings in idiopathic pernio: Is it a microvascular disease? Mod. Rheumatol. 2013, 23, 897–903. [Google Scholar] [CrossRef]
- Takci, Z.; Vahaboglu, G.; Eksioglu, H. Epidemiological patterns of perniosis, and its association with systemic disorder. Clin. Exp. Dermatol. 2012, 37, 844–849. [Google Scholar] [CrossRef]
- Viguier, M.; Pinquier, L.; Cavelier-Balloy, B.; de la Salmonière, P.; Cordoliani, F.; Flageul, B.; Morel, P.; Dubertret, L.; Bachelez, H. Clinical and histopathologic features and immunologic variables in patients with severe chilblains. A study of the relationship to lupus erythematosus. Medicine 2001, 80, 180–188. [Google Scholar] [CrossRef]
- Cappel, J.A.; Wetter, D.A. Clinical characteristics, etiologic associations, laboratory findings, treatment, and proposal of diagnostic criteria of pernio (chilblains) in a series of 104 patients at Mayo Clinic, 2000 to 2011. Mayo Clin. Proc. 2014, 89, 207–215. [Google Scholar] [CrossRef]
- Crowson, A.N.; Magro, C.M. Idiopathic perniosis and its mimics: A clinical and histological study of 38 cases. Hum. Pathol. 1997, 28, 478–484. [Google Scholar] [CrossRef]
- Boada, A.; Bielsa, I.; Fernández-Figueras, M.-T.; Ferrándiz, C. Perniosis: Clinical and histopathological analysis. Am. J. Dermatopathol. 2010, 32, 19–23. [Google Scholar] [CrossRef]
- Morgan, R.L.; Whaley, P.; Thayer, K.A.; Schunemann, H.J. Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes. Environ. Int. 2018, 121, 1027–1031. [Google Scholar] [CrossRef] [PubMed]
- Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Br. Med. J. 2021, 372, n71. [Google Scholar] [CrossRef]
- Kapnia, A.K.; Ziaka, S.; Flouris, A.D. Population Characteristics, Symptoms and Causes of Acute Perniosis/Chilblains. PROSPERO CRD42021245307. 2021. Available online: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021245307 (accessed on 10 May 2021).
- Gardinal-Galera, I.; Pajot, C.; Paul, C.; Mazereeuw-Hautier, J. Childhood chilblains is an uncommon and invalidant disease. Arch. Dis. Child. 2010, 95, 567–568. [Google Scholar] [CrossRef] [PubMed]
- Weston, W.L.; Morelli, J.G. Childhood pernio and cryoproteins. Pediatr. Dermatol. 2000, 17, 97–99. [Google Scholar] [CrossRef] [PubMed]
- Kearby, R.; Bowyer, S.; Sharrer, J.; Sharathkumar, A. Case report: Six-year-old girl with recurrent episodes of blue toes. Clin. Pediatr. 2010, 49, 495–498. [Google Scholar] [CrossRef] [PubMed]
- Ainsworth, B.E.; Haskell, W.L.; Herrmann, S.D.; Meckes, N.; Bassett, D.R., Jr.; Tudor-Locke, C.; Greer, J.L.; Vezina, J.; Whitt-Glover, M.C.; Leon, A.S. 2011 Compendium of Physical Activities: A second update of codes and MET values. Med. Sci. Sports Exerc. 2011, 43, 1575–1581. [Google Scholar] [CrossRef] [Green Version]
- Poulianiti, K.P.; Havenith, G.; Flouris, A.D. Metabolic energy cost of workers in agriculture, construction, manufacturing, tourism, and transportation industries. Ind. Health 2019, 57, 283–305. [Google Scholar] [CrossRef] [Green Version]
- Kapnia, A.K.; Ziaka, S.; Ioannou, L.G.; Flouri, I.; Dinas, P.C.; Flouris, A.D. Population characteristics, symptoms, and risk factors of idiopathic chilblains: A systematic review, meta-analysis, and meta-regression. Figshare. Dataset. Available online: https://figshare.com/articles/dataset/Population_characteristics_symptoms_and_risk_factors_of_idiopathic_chilblains_a_systematic_review_meta-analysis_and_meta-regression_/17708054 (accessed on 31 December 2021). [CrossRef]
- Viswanathan, M.; Berkman, N.D. Development of the RTI item bank on risk of bias and precision of observational studies. J. Clin. Epidemiol. 2012, 65, 163–178. [Google Scholar] [CrossRef]
- Margulis, A.V.; Pladevall, M.; Riera-Guardia, N.; Varas-Lorenzo, C.; Hazell, L.; Berkman, N.D.; Viswanathan, M.; Perez-Gutthann, S. Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: The Newcastle-Ottawa Scale and the RTI item bank. Clin. Epidemiol. 2014, 6, 359–368. [Google Scholar] [CrossRef]
- Al-Saleh, M.A.; Armijo-Olivo, S.; Thie, N.; Seikaly, H.; Boulanger, P.; Wolfaardt, J.; Major, P. Morphologic and functional changes in the temporomandibular joint and stomatognathic system after transmandibular surgery in oral and oropharyngeal cancers: Systematic review. J. Otolaryngol.-Head Neck Surg. 2012, 41, 345–360. [Google Scholar]
- Higgins, J.P.; Thomas, J.; Chandler, J.; Cumpston, M.; Li, T.; Page, M.J.; Welch, V.A. Cochrane Handbook for Systematic Reviews of Interventions; John Wiley & Sons: New York, NY, USA, 2019. [Google Scholar]
- Borden, K.A.; Cutter, S.L. Spatial patterns of natural hazards mortality in the United States. Int. J. Health Geogr. 2008, 7, 1–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Review Manager (RevMan) [Computer program], Version 5.4; The Cochrane Collaboration: London, UK, 2020.
- Higgins, J.P.; Thompson, S.G.; Deeks, J.J.; Altman, D.G. Measuring inconsistency in meta-analyses. Br. Med. J. 2003, 327, 557–560. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ioannou, L.G.; Tsoutsoubi, L.; Mantzios, K.; Flouris, A.D. A free software to predict heat strain according to the ISO 7933:2018. Ind. Health 2019, 57, 711–720. [Google Scholar] [CrossRef] [Green Version]
- Viechtbauer, W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 2010, 36, 1–48. [Google Scholar] [CrossRef] [Green Version]
- Ferrara, G.; Cerroni, L. Cold-associated perniosis of the thighs (“Equestrian-Type” chilblain): A reappraisal based on a clinicopathologic and immunohistochemical study of 6 cases. Am. J. Dermatopathol. 2016, 38, 726–731. [Google Scholar] [CrossRef]
- Cribier, B.; Djeridi, N.; Peltre, B.; Grosshans, E. A histologic and immunohistochemical study of chilblains. J. Am. Acad. Dermatol. 2001, 45, 924–929. [Google Scholar] [CrossRef]
- Wang, M.L.; Chan, M.P. Comparative analysis of chilblain lupus erythematosus and idiopathic perniosis: Histopathologic features and immunohistochemistry for CD123 and CD30. Am. J. Dermatopathol. 2018, 40, 265–271. [Google Scholar] [CrossRef]
- Chan, Y.; Tang, W.; Lam, W.Y.; Loo, S.; Li, S.; Au, A.; Leung, W.Y.; Kwan, C.K.; Lo, K.K. A cluster of chilblains in Hong Kong. Hong Kong Med. J. 2008, 14, 185–191. [Google Scholar]
- Shahi, V.; Wetter, D.A.; Cappel, J.A.; Davis, M.D.; Spittell, P.C. Vasospasm is a consistent finding in pernio (chilblains) and a possible clue to pathogenesis. Dermatology 2015, 231, 274–279. [Google Scholar] [CrossRef]
- Singh, G.K.; Datta, A.; Grewal, R.S.; Suresh, M.S.; Vaishampayan, S.S. Pattern of chilblains in a high altitude region of Ladakh, India. Med. J. Armed Forces India 2015, 71, 265–269. [Google Scholar] [CrossRef] [Green Version]
- Yang, X.; Perez, O.A.; English, J.C., 3rd. Successful treatment of perniosis with hydroxychloroquine. J. Drugs Dermatol. 2010, 9, 1242–1246. [Google Scholar] [PubMed]
- Al-Sudany, N.K. Treatment of primary perniosis with oral pentoxifylline (a double-blind placebo-controlled randomized therapeutic trial). Dermatol. Ther. 2016, 29, 263–268. [Google Scholar] [CrossRef] [PubMed]
- Külcü Çakmak, S.; Gönül, M.; Oğuz, I.; Yayla, D.; Gül, Ü.; Köse, K. Demographical, laboratory and associated findings in patients with perniosis. J. Eur. Acad. Dermatol. Venereol. 2014, 28, 891–894. [Google Scholar] [CrossRef]
- Flouris, A.D. Functional architecture of behavioural thermoregulation. Eur. J. Appl. Physiol. 2011, 111, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Tsoutsoubi, L.; Ioannou, L.G.; Mantzios, K.; Ziaka, S.; Nybo, L.; Flouris, A.D. Cardiovascular stress and characteristics of cold-induced vasodilation in women and men during cold-water immersion: A randomized control study. Biology 2022, 11, 1054. [Google Scholar] [CrossRef] [PubMed]
- Dinas, P.C.; Koutedakis, Y.; Flouris, A.D. Effects of active and passive tobacco cigarette smoking on heart rate variability. Int. J. Cardiol. 2013, 163, 109–115. [Google Scholar] [CrossRef]
- Benowitz, N.L.; Burbank, A.D. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends Cardiovasc. Med. 2016, 26, 515–523. [Google Scholar] [CrossRef] [Green Version]
- Olin, J.W.; Arrabi, W. Vascular diseases related to extremes in environmental temperature. In Peripheral Vascular Disease, 2nd ed.; Young, J.R., Olin, J.W., Bartholomew, J.R., Eds.; Mosby-Year Book Inc.: St Louis, Mo, USA, 1996; pp. 611–613. [Google Scholar]
- Jacob, J.R.; Weisman, M.H.; Rosenblatt, S.I.; Bookstein, J.J. Chronic pernio. A historical perspective of cold-induced vascular disease. Arch. Intern. Med. 1986, 146, 1589–1592. [Google Scholar] [CrossRef]
- Ioannidis, J. Next-generation systematic reviews: Prospective meta-analysis, individual-level data, networks and umbrella reviews. Br. J. Sports Med. 2017, 51, 1456–1458. [Google Scholar] [CrossRef]
Affected Skin Area | Histopathology Features | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hands | Fingers | Feet | Toes | Nose | Ears | Thighs | Legs | Ankles | Other | Necrotic Keratinocytes | Spongiosis | Perivascular Lymphcyticinfiltrate | Perieccrine Lymphocyticinfiltrate | Prominent Exocytosis | Basal Epidermal-Cell Layer Vaculation | Papillary Dermal Edema | ANAs | ||||
# | First Author, Date | Patients (M/F) | Mean Age | ||||||||||||||||||
1 | Wang et al., 2018 [31] | 14/25 | 39 | X | X | X | X | X | X | ||||||||||||
2 | Cappel & Wetter, 2014 [8] | 20/75 | 38 | X | X | X | |||||||||||||||
3 | Boada et al., 2010 [10] | 1/7 | 46 | X | X | X | X | X | X | X | X | X | X | ||||||||
4 | Ferrara & Cerroni, 2016 [29] | 0/6 | 33 | X | X | X | X | X | X | ||||||||||||
5 | Çakmak et al., 2014 [37] | 11/14 | 24 | X | X | X | |||||||||||||||
6 | Ozmen et al., 2013 [5] | 18/35 | 25 | X | X | X | X | X | X | ||||||||||||
7 | Shahi et al., 2015 [33] | 1/1 | 43 | X | X | X | X | X | X | ||||||||||||
8 | Cribier et al., 2001 [30] | 5/12 | 17 | X | X | X | X | X | X | ||||||||||||
9 | Viguier et al., 2001 [7] | 4/6 | 30 | X | X | X | X | X | X | X | X | X | X | X | |||||||
10 | Chan et al., 2008 [32] | 2/1 | 60 | X | X | X | |||||||||||||||
11 | Singh et al., 2015 [34] | 97/11 | 30 | X | X | X | |||||||||||||||
12 | Yang et al., 2010 [35] | 0/1 | 33 | X | X | ||||||||||||||||
13 | Al-Sudany, 2016 [36] | 32/78 | 25 | X | X | X | |||||||||||||||
% of studies reporting an affected area → | 62 | 54 | 46 | 38 | 31 | 23 | 15 | 8 | 8 | 8 |
# | Signs/Symptoms | Percent of Patients |
---|---|---|
1 | Papules | 20.7 |
2 | Nodules | 13.6 |
3 | Itching/pruritus | 10.2 |
4 | Edema | 6.2 |
5 | Macules | 6.2 |
6 | Erythema and edema | 5.8 |
7 | Erythema | 5.4 |
8 | Cyanosis | 5.2 |
9 | Coldness | 4.7 |
10 | Pigmentation with erythema/edema | 3.8 |
11 | Paresthesia and numbness | 2.8 |
12 | Dusky rash | 2.7 |
13 | Skin burning sensation | 2.7 |
14 | Swelling | 2.7 |
15 | Skin sensitivity | 2.6 |
16 | Ulcers | 1.9 |
17 | Desquamation | 1.1 |
18 | Erythema, edema with vesicles | 0.7 |
19 | Erythema, edema with ulcers | 0.5 |
20 | Bullae | 0.4 |
21 | Scar | 0.1 |
# | Outcome | Studies Included | Patients | Prevalence | I2 | Risk of Bias (%) | Certainty | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A | B | C | D | E | F | |||||||
1 | Prevalence of perivascular lymphocytic infiltrate | 3 | 56 | 0.81 [0.66–0.96] | 0% | 0 | 0 | 0 | 0 | 0 | 33 | Low ⊕⊕⊖⊖ |
2 | Prevalence of basal epidermal-cell layer vacuolation | 3 | 37 | 0.67 [0.45–0.90] | 0% | 0 | 0 | 0 | 33 | 67 | 33 | Low ⊕⊕⊖⊖ |
3 | Prevalence of papillary dermal edema | 3 | 33 | 0.66 [0.44–0.88] | 0% | 0 | 0 | 0 | 0 | 0 | 0 | Low ⊕⊕⊖⊖ |
4 | Prevalence of perieccrine lymphocytic infiltrate | 4 | 35 | 0.57 [0.21–0.71] | 0% | 0 | 0 | 0 | 0 | 25 | 50 | Low ⊕⊕⊖⊖ |
5 | Prevalence of necrotic keratinocytes | 4 | 20 | 0.50 [0.27–0.72] | 0% | 0 | 0 | 0 | 25 | 50 | 50 | Low ⊕⊕⊖⊖ |
6 | Prevalence of spongiosis | 3 | 11 | 0.40 [0.12–0.67] | 33% | 0 | 0 | 0 | 0 | 33 | 67 | Low ⊕⊕⊖⊖ |
7 | Prevalence of prominent exocytosis | 3 | 23 | 0.31 [0.22–0.96] | 51% | 0 | 0 | 0 | 0 | 0 | 33 | Low ⊕⊕⊖⊖ |
8 | Prevalence of ANAs | 3 | 10 | 0.25 [−0.03–0.52] | 95% | 0 | 0 | 0 | 0 | 0 | 0 | Very low ⊕⊖⊖⊖ |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kapnia, A.K.; Ziaka, S.; Ioannou, L.G.; Flouri, I.; Dinas, P.C.; Flouris, A.D. Population Characteristics, Symptoms, and Risk Factors of Idiopathic Chilblains: A Systematic Review, Meta-Analysis, and Meta-Regression. Biology 2022, 11, 1651. https://doi.org/10.3390/biology11111651
Kapnia AK, Ziaka S, Ioannou LG, Flouri I, Dinas PC, Flouris AD. Population Characteristics, Symptoms, and Risk Factors of Idiopathic Chilblains: A Systematic Review, Meta-Analysis, and Meta-Regression. Biology. 2022; 11(11):1651. https://doi.org/10.3390/biology11111651
Chicago/Turabian StyleKapnia, Areti K., Styliani Ziaka, Leonidas G. Ioannou, Irini Flouri, Petros C. Dinas, and Andreas D. Flouris. 2022. "Population Characteristics, Symptoms, and Risk Factors of Idiopathic Chilblains: A Systematic Review, Meta-Analysis, and Meta-Regression" Biology 11, no. 11: 1651. https://doi.org/10.3390/biology11111651
APA StyleKapnia, A. K., Ziaka, S., Ioannou, L. G., Flouri, I., Dinas, P. C., & Flouris, A. D. (2022). Population Characteristics, Symptoms, and Risk Factors of Idiopathic Chilblains: A Systematic Review, Meta-Analysis, and Meta-Regression. Biology, 11(11), 1651. https://doi.org/10.3390/biology11111651